ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiotheranostic Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-29X14386
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Radiotheranostic Market Research Report 2023
BUY CHAPTERS

Global Radiotheranostic Market Research Report 2025

Code: QYRE-Auto-29X14386
Report
April 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
Theragnostics
NuView Life Sciences
Jubilant Pharma Limited
Clarity Pharmaceuticals
GE Healthcare Inc
Bayer
Lantheus Medical
Imaging
Novartis
Spectrum Pharmaceuticals Inc
Ipsen S A
Nordic Nanovector ASA
Y-mAbs Therapeutics,Inc
Terumo Corporation
Sirtex Medical Limited
Boston Scientific Corporation
Nihon Medi-Physics
Curium SAS
Actinium Pharmaceuticals, Inc. (ATNM)
Sofie Biosciences, Inc.
TransCode Therapeutics, Inc.

Radiotheranostic Market

The global market for Radiotheranostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The field of radiotheranostic, which combines diagnostic and therapeutic applications of radiopharmaceuticals, is experiencing growth as it allows for more precise cancer diagnosis and treatment planning. Advances in targeted radiopharmaceuticals and imaging techniques are driving this trend.
This report aims to provide a comprehensive presentation of the global market for Radiotheranostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiotheranostic.
The Radiotheranostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiotheranostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiotheranostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Radiotheranostic Market Report

Report Metric Details
Report Name Radiotheranostic Market
Segment by Type
  • Nuclear Reactors
  • Cyclotrons
Segment by Application
  • Oncology
  • Non-Oncology
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Clarity Pharmaceuticals., TransCode Therapeutics, Inc., Curium SAS, GE Healthcare Inc., Bayer AG, Lantheus Medical, Imaging, Inc., Novartis AG, Spectrum Pharmaceuticals, Inc., Ipsen S.A., Actinium Pharmaceuticals, Inc. (ATNM), Nordic Nanovector ASA, Y-mAbs Therapeutics, Inc., Sofie Biosciences, Inc., Terumo Corporation, Sirtex Medical Limited, Boston Scientific Corporation, Nihon Medi-Physics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Radiotheranostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radiotheranostic Market report?

Ans: The main players in the Radiotheranostic Market are ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Clarity Pharmaceuticals., TransCode Therapeutics, Inc., Curium SAS, GE Healthcare Inc., Bayer AG, Lantheus Medical, Imaging, Inc., Novartis AG, Spectrum Pharmaceuticals, Inc., Ipsen S.A., Actinium Pharmaceuticals, Inc. (ATNM), Nordic Nanovector ASA, Y-mAbs Therapeutics, Inc., Sofie Biosciences, Inc., Terumo Corporation, Sirtex Medical Limited, Boston Scientific Corporation, Nihon Medi-Physics

What are the Application segmentation covered in the Radiotheranostic Market report?

Ans: The Applications covered in the Radiotheranostic Market report are Oncology, Non-Oncology

What are the Type segmentation covered in the Radiotheranostic Market report?

Ans: The Types covered in the Radiotheranostic Market report are Nuclear Reactors, Cyclotrons

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiotheranostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nuclear Reactors
1.2.3 Cyclotrons
1.3 Market by Application
1.3.1 Global Radiotheranostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Non-Oncology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiotheranostic Market Perspective (2020-2031)
2.2 Global Radiotheranostic Growth Trends by Region
2.2.1 Global Radiotheranostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiotheranostic Historic Market Size by Region (2020-2025)
2.2.3 Radiotheranostic Forecasted Market Size by Region (2026-2031)
2.3 Radiotheranostic Market Dynamics
2.3.1 Radiotheranostic Industry Trends
2.3.2 Radiotheranostic Market Drivers
2.3.3 Radiotheranostic Market Challenges
2.3.4 Radiotheranostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiotheranostic Players by Revenue
3.1.1 Global Top Radiotheranostic Players by Revenue (2020-2025)
3.1.2 Global Radiotheranostic Revenue Market Share by Players (2020-2025)
3.2 Global Radiotheranostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiotheranostic Revenue
3.4 Global Radiotheranostic Market Concentration Ratio
3.4.1 Global Radiotheranostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiotheranostic Revenue in 2024
3.5 Global Key Players of Radiotheranostic Head office and Area Served
3.6 Global Key Players of Radiotheranostic, Product and Application
3.7 Global Key Players of Radiotheranostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiotheranostic Breakdown Data by Type
4.1 Global Radiotheranostic Historic Market Size by Type (2020-2025)
4.2 Global Radiotheranostic Forecasted Market Size by Type (2026-2031)
5 Radiotheranostic Breakdown Data by Application
5.1 Global Radiotheranostic Historic Market Size by Application (2020-2025)
5.2 Global Radiotheranostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiotheranostic Market Size (2020-2031)
6.2 North America Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiotheranostic Market Size by Country (2020-2025)
6.4 North America Radiotheranostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiotheranostic Market Size (2020-2031)
7.2 Europe Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiotheranostic Market Size by Country (2020-2025)
7.4 Europe Radiotheranostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiotheranostic Market Size (2020-2031)
8.2 Asia-Pacific Radiotheranostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiotheranostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiotheranostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiotheranostic Market Size (2020-2031)
9.2 Latin America Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiotheranostic Market Size by Country (2020-2025)
9.4 Latin America Radiotheranostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiotheranostic Market Size (2020-2031)
10.2 Middle East & Africa Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiotheranostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiotheranostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ITM Isotopen Technologien München AG
11.1.1 ITM Isotopen Technologien München AG Company Details
11.1.2 ITM Isotopen Technologien München AG Business Overview
11.1.3 ITM Isotopen Technologien München AG Radiotheranostic Introduction
11.1.4 ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2020-2025)
11.1.5 ITM Isotopen Technologien München AG Recent Development
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Details
11.2.2 Advanced Accelerator Applications Business Overview
11.2.3 Advanced Accelerator Applications Radiotheranostic Introduction
11.2.4 Advanced Accelerator Applications Revenue in Radiotheranostic Business (2020-2025)
11.2.5 Advanced Accelerator Applications Recent Development
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Details
11.3.2 Telix Pharmaceuticals Business Overview
11.3.3 Telix Pharmaceuticals Radiotheranostic Introduction
11.3.4 Telix Pharmaceuticals Revenue in Radiotheranostic Business (2020-2025)
11.3.5 Telix Pharmaceuticals Recent Development
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Details
11.4.2 Theragnostics Ltd. Business Overview
11.4.3 Theragnostics Ltd. Radiotheranostic Introduction
11.4.4 Theragnostics Ltd. Revenue in Radiotheranostic Business (2020-2025)
11.4.5 Theragnostics Ltd. Recent Development
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Details
11.5.2 NuView Life Sciences Business Overview
11.5.3 NuView Life Sciences Radiotheranostic Introduction
11.5.4 NuView Life Sciences Revenue in Radiotheranostic Business (2020-2025)
11.5.5 NuView Life Sciences Recent Development
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Details
11.6.2 Jubilant Pharma Limited Business Overview
11.6.3 Jubilant Pharma Limited Radiotheranostic Introduction
11.6.4 Jubilant Pharma Limited Revenue in Radiotheranostic Business (2020-2025)
11.6.5 Jubilant Pharma Limited Recent Development
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Details
11.7.2 Clarity Pharmaceuticals. Business Overview
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Introduction
11.7.4 Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2020-2025)
11.7.5 Clarity Pharmaceuticals. Recent Development
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Details
11.8.2 TransCode Therapeutics, Inc. Business Overview
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Introduction
11.8.4 TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.8.5 TransCode Therapeutics, Inc. Recent Development
11.9 Curium SAS
11.9.1 Curium SAS Company Details
11.9.2 Curium SAS Business Overview
11.9.3 Curium SAS Radiotheranostic Introduction
11.9.4 Curium SAS Revenue in Radiotheranostic Business (2020-2025)
11.9.5 Curium SAS Recent Development
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Details
11.10.2 GE Healthcare Inc. Business Overview
11.10.3 GE Healthcare Inc. Radiotheranostic Introduction
11.10.4 GE Healthcare Inc. Revenue in Radiotheranostic Business (2020-2025)
11.10.5 GE Healthcare Inc. Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Radiotheranostic Introduction
11.11.4 Bayer AG Revenue in Radiotheranostic Business (2020-2025)
11.11.5 Bayer AG Recent Development
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Details
11.12.2 Lantheus Medical Business Overview
11.12.3 Lantheus Medical Radiotheranostic Introduction
11.12.4 Lantheus Medical Revenue in Radiotheranostic Business (2020-2025)
11.12.5 Lantheus Medical Recent Development
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Details
11.13.2 Imaging, Inc. Business Overview
11.13.3 Imaging, Inc. Radiotheranostic Introduction
11.13.4 Imaging, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.13.5 Imaging, Inc. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Radiotheranostic Introduction
11.14.4 Novartis AG Revenue in Radiotheranostic Business (2020-2025)
11.14.5 Novartis AG Recent Development
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Details
11.15.2 Spectrum Pharmaceuticals, Inc. Business Overview
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Introduction
11.15.4 Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.15.5 Spectrum Pharmaceuticals, Inc. Recent Development
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Details
11.16.2 Ipsen S.A. Business Overview
11.16.3 Ipsen S.A. Radiotheranostic Introduction
11.16.4 Ipsen S.A. Revenue in Radiotheranostic Business (2020-2025)
11.16.5 Ipsen S.A. Recent Development
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Details
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Introduction
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2020-2025)
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Details
11.18.2 Nordic Nanovector ASA Business Overview
11.18.3 Nordic Nanovector ASA Radiotheranostic Introduction
11.18.4 Nordic Nanovector ASA Revenue in Radiotheranostic Business (2020-2025)
11.18.5 Nordic Nanovector ASA Recent Development
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Details
11.19.2 Y-mAbs Therapeutics, Inc. Business Overview
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Introduction
11.19.4 Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.19.5 Y-mAbs Therapeutics, Inc. Recent Development
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Details
11.20.2 Sofie Biosciences, Inc. Business Overview
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Introduction
11.20.4 Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.20.5 Sofie Biosciences, Inc. Recent Development
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Details
11.21.2 Terumo Corporation Business Overview
11.21.3 Terumo Corporation Radiotheranostic Introduction
11.21.4 Terumo Corporation Revenue in Radiotheranostic Business (2020-2025)
11.21.5 Terumo Corporation Recent Development
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Details
11.22.2 Sirtex Medical Limited Business Overview
11.22.3 Sirtex Medical Limited Radiotheranostic Introduction
11.22.4 Sirtex Medical Limited Revenue in Radiotheranostic Business (2020-2025)
11.22.5 Sirtex Medical Limited Recent Development
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Details
11.23.2 Boston Scientific Corporation Business Overview
11.23.3 Boston Scientific Corporation Radiotheranostic Introduction
11.23.4 Boston Scientific Corporation Revenue in Radiotheranostic Business (2020-2025)
11.23.5 Boston Scientific Corporation Recent Development
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Details
11.24.2 Nihon Medi-Physics Business Overview
11.24.3 Nihon Medi-Physics Radiotheranostic Introduction
11.24.4 Nihon Medi-Physics Revenue in Radiotheranostic Business (2020-2025)
11.24.5 Nihon Medi-Physics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
Theragnostics
NuView Life Sciences
Jubilant Pharma Limited
Clarity Pharmaceuticals
GE Healthcare Inc
Bayer
Lantheus Medical
Imaging
Novartis
Spectrum Pharmaceuticals Inc
Ipsen S A
Nordic Nanovector ASA
Y-mAbs Therapeutics,Inc
Terumo Corporation
Sirtex Medical Limited
Boston Scientific Corporation
Nihon Medi-Physics
Curium SAS
Actinium Pharmaceuticals, Inc. (ATNM)
Sofie Biosciences, Inc.
TransCode Therapeutics, Inc.
List of Tables
 Table 1. Global Radiotheranostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Nuclear Reactors
 Table 3. Key Players of Cyclotrons
 Table 4. Global Radiotheranostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Radiotheranostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Radiotheranostic Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Radiotheranostic Market Share by Region (2020-2025)
 Table 8. Global Radiotheranostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Radiotheranostic Market Share by Region (2026-2031)
 Table 10. Radiotheranostic Market Trends
 Table 11. Radiotheranostic Market Drivers
 Table 12. Radiotheranostic Market Challenges
 Table 13. Radiotheranostic Market Restraints
 Table 14. Global Radiotheranostic Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Radiotheranostic Market Share by Players (2020-2025)
 Table 16. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2024)
 Table 17. Ranking of Global Top Radiotheranostic Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Radiotheranostic Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Radiotheranostic, Headquarters and Area Served
 Table 20. Global Key Players of Radiotheranostic, Product and Application
 Table 21. Global Key Players of Radiotheranostic, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Radiotheranostic Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Radiotheranostic Revenue Market Share by Type (2020-2025)
 Table 25. Global Radiotheranostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Radiotheranostic Revenue Market Share by Type (2026-2031)
 Table 27. Global Radiotheranostic Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Radiotheranostic Revenue Market Share by Application (2020-2025)
 Table 29. Global Radiotheranostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Radiotheranostic Revenue Market Share by Application (2026-2031)
 Table 31. North America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Radiotheranostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Radiotheranostic Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Radiotheranostic Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
 Table 46. ITM Isotopen Technologien München AG Company Details
 Table 47. ITM Isotopen Technologien München AG Business Overview
 Table 48. ITM Isotopen Technologien München AG Radiotheranostic Product
 Table 49. ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 50. ITM Isotopen Technologien München AG Recent Development
 Table 51. Advanced Accelerator Applications Company Details
 Table 52. Advanced Accelerator Applications Business Overview
 Table 53. Advanced Accelerator Applications Radiotheranostic Product
 Table 54. Advanced Accelerator Applications Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 55. Advanced Accelerator Applications Recent Development
 Table 56. Telix Pharmaceuticals Company Details
 Table 57. Telix Pharmaceuticals Business Overview
 Table 58. Telix Pharmaceuticals Radiotheranostic Product
 Table 59. Telix Pharmaceuticals Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 60. Telix Pharmaceuticals Recent Development
 Table 61. Theragnostics Ltd. Company Details
 Table 62. Theragnostics Ltd. Business Overview
 Table 63. Theragnostics Ltd. Radiotheranostic Product
 Table 64. Theragnostics Ltd. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 65. Theragnostics Ltd. Recent Development
 Table 66. NuView Life Sciences Company Details
 Table 67. NuView Life Sciences Business Overview
 Table 68. NuView Life Sciences Radiotheranostic Product
 Table 69. NuView Life Sciences Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 70. NuView Life Sciences Recent Development
 Table 71. Jubilant Pharma Limited Company Details
 Table 72. Jubilant Pharma Limited Business Overview
 Table 73. Jubilant Pharma Limited Radiotheranostic Product
 Table 74. Jubilant Pharma Limited Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 75. Jubilant Pharma Limited Recent Development
 Table 76. Clarity Pharmaceuticals. Company Details
 Table 77. Clarity Pharmaceuticals. Business Overview
 Table 78. Clarity Pharmaceuticals. Radiotheranostic Product
 Table 79. Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 80. Clarity Pharmaceuticals. Recent Development
 Table 81. TransCode Therapeutics, Inc. Company Details
 Table 82. TransCode Therapeutics, Inc. Business Overview
 Table 83. TransCode Therapeutics, Inc. Radiotheranostic Product
 Table 84. TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 85. TransCode Therapeutics, Inc. Recent Development
 Table 86. Curium SAS Company Details
 Table 87. Curium SAS Business Overview
 Table 88. Curium SAS Radiotheranostic Product
 Table 89. Curium SAS Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 90. Curium SAS Recent Development
 Table 91. GE Healthcare Inc. Company Details
 Table 92. GE Healthcare Inc. Business Overview
 Table 93. GE Healthcare Inc. Radiotheranostic Product
 Table 94. GE Healthcare Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 95. GE Healthcare Inc. Recent Development
 Table 96. Bayer AG Company Details
 Table 97. Bayer AG Business Overview
 Table 98. Bayer AG Radiotheranostic Product
 Table 99. Bayer AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 100. Bayer AG Recent Development
 Table 101. Lantheus Medical Company Details
 Table 102. Lantheus Medical Business Overview
 Table 103. Lantheus Medical Radiotheranostic Product
 Table 104. Lantheus Medical Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 105. Lantheus Medical Recent Development
 Table 106. Imaging, Inc. Company Details
 Table 107. Imaging, Inc. Business Overview
 Table 108. Imaging, Inc. Radiotheranostic Product
 Table 109. Imaging, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 110. Imaging, Inc. Recent Development
 Table 111. Novartis AG Company Details
 Table 112. Novartis AG Business Overview
 Table 113. Novartis AG Radiotheranostic Product
 Table 114. Novartis AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 115. Novartis AG Recent Development
 Table 116. Spectrum Pharmaceuticals, Inc. Company Details
 Table 117. Spectrum Pharmaceuticals, Inc. Business Overview
 Table 118. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product
 Table 119. Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 120. Spectrum Pharmaceuticals, Inc. Recent Development
 Table 121. Ipsen S.A. Company Details
 Table 122. Ipsen S.A. Business Overview
 Table 123. Ipsen S.A. Radiotheranostic Product
 Table 124. Ipsen S.A. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 125. Ipsen S.A. Recent Development
 Table 126. Actinium Pharmaceuticals, Inc. (ATNM) Company Details
 Table 127. Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
 Table 128. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product
 Table 129. Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 130. Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
 Table 131. Nordic Nanovector ASA Company Details
 Table 132. Nordic Nanovector ASA Business Overview
 Table 133. Nordic Nanovector ASA Radiotheranostic Product
 Table 134. Nordic Nanovector ASA Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 135. Nordic Nanovector ASA Recent Development
 Table 136. Y-mAbs Therapeutics, Inc. Company Details
 Table 137. Y-mAbs Therapeutics, Inc. Business Overview
 Table 138. Y-mAbs Therapeutics, Inc. Radiotheranostic Product
 Table 139. Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 140. Y-mAbs Therapeutics, Inc. Recent Development
 Table 141. Sofie Biosciences, Inc. Company Details
 Table 142. Sofie Biosciences, Inc. Business Overview
 Table 143. Sofie Biosciences, Inc. Radiotheranostic Product
 Table 144. Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 145. Sofie Biosciences, Inc. Recent Development
 Table 146. Terumo Corporation Company Details
 Table 147. Terumo Corporation Business Overview
 Table 148. Terumo Corporation Radiotheranostic Product
 Table 149. Terumo Corporation Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 150. Terumo Corporation Recent Development
 Table 151. Sirtex Medical Limited Company Details
 Table 152. Sirtex Medical Limited Business Overview
 Table 153. Sirtex Medical Limited Radiotheranostic Product
 Table 154. Sirtex Medical Limited Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 155. Sirtex Medical Limited Recent Development
 Table 156. Boston Scientific Corporation Company Details
 Table 157. Boston Scientific Corporation Business Overview
 Table 158. Boston Scientific Corporation Radiotheranostic Product
 Table 159. Boston Scientific Corporation Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 160. Boston Scientific Corporation Recent Development
 Table 161. Nihon Medi-Physics Company Details
 Table 162. Nihon Medi-Physics Business Overview
 Table 163. Nihon Medi-Physics Radiotheranostic Product
 Table 164. Nihon Medi-Physics Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
 Table 165. Nihon Medi-Physics Recent Development
 Table 166. Research Programs/Design for This Report
 Table 167. Key Data Information from Secondary Sources
 Table 168. Key Data Information from Primary Sources
 Table 169. Authors List of This Report


List of Figures
 Figure 1. Radiotheranostic Picture
 Figure 2. Global Radiotheranostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Radiotheranostic Market Share by Type: 2024 VS 2031
 Figure 4. Nuclear Reactors Features
 Figure 5. Cyclotrons Features
 Figure 6. Global Radiotheranostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Radiotheranostic Market Share by Application: 2024 VS 2031
 Figure 8. Oncology Case Studies
 Figure 9. Non-Oncology Case Studies
 Figure 10. Radiotheranostic Report Years Considered
 Figure 11. Global Radiotheranostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Radiotheranostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Radiotheranostic Market Share by Region: 2024 VS 2031
 Figure 14. Global Radiotheranostic Market Share by Players in 2024
 Figure 15. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Radiotheranostic Revenue in 2024
 Figure 17. North America Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Radiotheranostic Market Share by Country (2020-2031)
 Figure 19. United States Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Radiotheranostic Market Share by Country (2020-2031)
 Figure 23. Germany Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Radiotheranostic Market Share by Region (2020-2031)
 Figure 31. China Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Radiotheranostic Market Share by Country (2020-2031)
 Figure 39. Mexico Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Radiotheranostic Market Share by Country (2020-2031)
 Figure 43. Turkey Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. ITM Isotopen Technologien München AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 47. Advanced Accelerator Applications Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 48. Telix Pharmaceuticals Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 49. Theragnostics Ltd. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 50. NuView Life Sciences Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 51. Jubilant Pharma Limited Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 52. Clarity Pharmaceuticals. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 53. TransCode Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 54. Curium SAS Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 55. GE Healthcare Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 56. Bayer AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 57. Lantheus Medical Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 58. Imaging, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 59. Novartis AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 60. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 61. Ipsen S.A. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 62. Actinium Pharmaceuticals, Inc. (ATNM) Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 63. Nordic Nanovector ASA Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 64. Y-mAbs Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 65. Sofie Biosciences, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 66. Terumo Corporation Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 67. Sirtex Medical Limited Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 68. Boston Scientific Corporation Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 69. Nihon Medi-Physics Revenue Growth Rate in Radiotheranostic Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Oncology Radiopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radioisotope Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiation Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Imaging Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Targeted Radionuclide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Science Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiosensitizer Market Research Report 2025
Medical Hyperthermia System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiotherapy Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiation Bra Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiology Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical for Nuclear Medicine Market Research Report 2024
Radiation Emergency Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiotherapy Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
RF Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiative Cooling Material Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiometers Market Research Report 2024
Heliostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RF Hyperthermia Machine Market Research Report 2025
Radiation Therapy Skin Care Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions